Boon’s production facility is complete and sees an increase in new orders as a result of its newly certified Good Manufacturing Practices
SACRAMENTO, CA – (NewMediaWire) – March 17, 2022 – Boon Industries, Inc. (OTC PINK: BNOW) (“Boon” or the “Company”), an environmentally conscious bioscience company delivering solutions that benefit people and the planet, is pleased to announce that its production facility is complete, and an increase in new orders as a result of its newly certified Good Manufacturing Practice (cGMP) status for its production facility in Grass Valley.
Justin Gonzalez, Chairman, stated, “The new facility will produce over one thousand gallons of BioDox or Diox+ per day, which represents revenue of approximately $300,000 per day. This allows for an annual revenue to meet demand of approximately $78M before expansion would be required. BioDox is bottled in a concentrated formula that is sold by the quart for $89 or by the gallon for $229.“
This escalation in sales validates and aligns with Boon Industries’ belief that the cGMP status stimulates and expedites ongoing anchor level relationships. Boon’s customer acquisition costs and ratio to establishing new customers is 1:2. The customers are repeat and will purchase an estimated $.50 per sq ft of BioDox. The farms range from 10,000 sq. ft. to 10,000 acres.
Mr. Gonzalez further stated, “The agriculture markets allow Boon to generate sales as a 25(b) product while waiting for EPA approval for other applications, and Boon is currently developing sales in these markets. We believe our current success in the agriculture industry will be relative to the pending EPA compliant industries such as medical, hospitality and warehousing that as the Company accomplishes these compliance milestones we will continue to see an increase of revenue from larger distributors for our products as we expand into new markets.”
About Boon Industries
Boon Industries, Inc. (OTC:BNOW) is an innovative bioscience company delivering solutions that benefit people and the planet. At the core of Boon’s product offering is DiOx+™ and BioDox™, a chlorine dioxide disinfectant sterilizer. Chlorine dioxide has been approved by OSHA, FDA, EPA, and DOT. DiOx+ kills harmful pathogens without dangerous toxic exposure to the user or the environment. The proprietary chemical formulas and processes behind Boon’s products make it ideal for sterilization of mission critical, high value medical equipment and disinfecting air and surfaces in laboratory and hospital environments. BioDox™ helps prevent agricultural crops from disease. Diox+™ is used in water treatment plants, and helps reduce operational costs in warehousing, distribution centers and ecommerce support facilities. The introduction of DiOx+ to the U.S. market follows 12 years of chlorine dioxide usage in global markets driven by Boon’s CEO Justin Gonzalez. DiOx+ delivers on Boon’s promise to provide the most effective, affordable solutions without sacrificing health and safety. DiOx+ is produced at Boon’s manufacturing facility and corporate headquarters in Grass Valley, California.
Safe Harbor for Forward-Looking Statements: This news release contains forward-looking statements which are not statements of historical fact. Forward-looking statements include estimates and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “will”, or “plan”. Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management’s expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include but are not limited to changes in general economic and financial market conditions. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
Please note that from time to time the Company may post new information at its website boonindustries.com, or via its current social media accounts below:
The Company’s most current Investor Presentation is available at the following link:
Boon Industries, Inc.
Investor Relations & Financial Media
Integrity Media Inc.
Toll Free: (888) 216-3595